Oncology Data Advisor® · Aligning Treatment Goals and Value-Based Care in Multiple Myeloma With Joseph Kalis, PharmD Pharmacy Podcast Network: You are listening to the Pharmacy Podcast Network (PPN). New technologies are leading to deeper responses and longer survival for patients with multiple myeloma. But these complex care plans lead ...

Oncology Data Advisor® · Creating Welcoming Spaces for LGBTQ+ Cancer Survivorship Care At the 48th Annual Oncology Nursing Society (ONS) Congress, Dr. Megan Mullins, an Assistant Professor at the University of Texas (UT) Southwestern Cancer Center, gave a presentation on improving cancer survivorship for sexual and gender minorities. In ...

Oncology Data Advisor® · Inspiring a Fulfilling Career in Nursing With Lauren Ghazal, PhD, FNP-BC In this interview from the Oncology Nursing Society (ONS) 2023 Congress, Oncology Data Advisor speaks with Lauren Ghazal, PhD, FNP-BC, a Family Nurse Practitioner and Post-Doctoral Research Fellow at the University of Michigan. Dr. Ghazal was honored at ONS Congress as a recipient of the 2023 Mara Mogensen Flaherty Memorial Lectureship Award to discuss "Current Challenges: Nursing Sustainability" along with fellow recipients Suzanne Carroll, RN, MS, AOCN®; Amy E. Rettig, DNP, MALM, MSN, BSN, RN ACNS-BC, PMHNP-BC; and 2000 Mara Mogensen Flaherty Memorial Lectureship Award recipient Debi Boyle, MSN, RN, AOCNS®,FAAN, serving as moderator. In this interview, Dr. Ghazal highlights her inspiring work and research investigating nursing sustainability and cancer survivorship for adolescents and young adults, and shares how to encourage more individuals to pursue a fulfilling career in nursing and research.  

Oncology Data Advisor® · Unleashing the Power of Therapy Dogs for Cancer Patients: Colleen Stoner and Diane Haley, LCSW Therapy animals can deliver profound psychological, physiological, emotional, and social benefits for patients with cancer. At the recent 48th Annual Oncology Nursing Society (ONS) Congress, Colleen Stoner, Manager of Volunteer Leaders at Pet Partners, and Diane Haley, LCSW, Director of Patient Experience at Rutgers Cancer Institute of New Jersey, gave a presentation titled UnLEASHing the Power of Pet Therapy: How to Integrate Pet Therapy Into Your Cancer Center. Afterwards, they sat down with Oncology Data Advisor to elaborate on the powerful impacts that therapy animals can have on the experiences of patients with cancer.  

Oncology Data Advisor® · Reflecting on Body Image for Women With Head and Neck Cancer: Colette Baudoin, PhD, RN In this interview from the 48th Annual Oncology Nursing Society (ONS) Congress, Oncology Data Advisor speaks with Colette Baudoin, a Clinical Instructor of Nursing at Louisiana State University's School of Nursing. Ms. Baudoin shares her research regarding the lived experience of body image in women who are receiving treatment for head and neck cancer, including ways for the health care community to support this unique population.  

Oncology Data Advisor® · Validating Oncology Nursing Experience Through ONCC Certification: Tony Ellis, MSEd, CAE, ICE-CCP Recently, the Oncology Nursing Certification Corporation (ONCC) unveiled its new logo, which embraces the diversity and the passion behind oncology nursing. In this interview, Tony Ellis, MSEd, CAE, ICE-CCP, the Executive Director of ONCC, shares the features of their recently rebranded website and the benefits of obtaining ONCC certification, as well as steps and tips for nurses who are interested in becoming certified.  

Oncology Data Advisor® · Exploring Virtual Reality for Patients With Brain Cancer: Amanda King, APNP-BC In this interview from the 48th Annual Oncology Nursing Society (ONS) Congress, Oncology Data Advisor talks with Amanda King, PhD, APNP-BC, a Nurse Scientist at the National Institutes of Health, about her innovative approach to address distress and anxiety experienced by patients with brain cancer through the use of virtual reality.  

Oncology Data Advisor® · Strengthening Nursing Sustainability: Amy Rettig, DNP, RN, APRN-BC At the recent 48th Oncology Nursing Society (ONS) Congress, Amy Rettig, DNP, RN, APRN-BC, sat down with Oncology Data Advisor® to discuss her presentation focused on intentional facilitated conversations to promote nursing sustainability.  

Oncology Data Advisor® · Informed Approach to Emotional Trauma for Cancer Patients: Elizabeth Archer-Nanda and Meagan Dwyer In this interview from the 48th Oncology Nursing Society (ONS) Congress, Elizabeth Archer-Nanda, Founding Member of the Behavioral Oncology Program and Clinical Director of Advanced Practice Providers at Norton Cancer Institute, and Meagan Dwyer, a Licensed Clinical Psychologist, discuss their presentation Compassionate Cancer Care: A Trauma-Informed Approach to Mental and Emotional Patient Health Needs. Their talk encompasses the mental health concerns experienced by cancer patients and how clinicians can apply self-care with a trauma-informed approach.  

Oncology Data Advisor® · Bolstering Leadership Skills in Oncology Nursing: Nick Escobedo, DNP, RN At the recent 48th Oncology Nursing Society (ONS) Congress, Nick Escobedo, an Oncology Nurse and Director of Inpatient Services for Oncology at Houston Methodist Hospital in Houston, Texas, sat down with Oncology Data Advisor to discuss his presentation titled Developing New Oncology Nurse Leaders, in which he provides valuable advice and resources to bolster the oncology nursing staff leadership.  

Oncology Data Advisor® · Live Podcasts From the 2023 Oncology Nursing Society (ONS) Congress: Part 1 At the 48th Annual Oncology Nursing Society (ONS) Congress in San Antonio, Texas, Oncology Data Advisor had the privilege of interviewing many distinguished nursing speakers about their research. This ONS Congress playlist features podcas...

Oncology Data Advisor® · Health Care Violence Trends And Prevention Strategies: Scott Christensen, DNP, MBA, APRN, ACNP-BC At the recent Oncology Nursing Society (ONS) Congress held in San Antonio, Texas, Oncology Data Advisor spoke with Dr. Scott Christensen, Senior Nursing Director at the University of Utah Health, about his session focusing on safety and violence in health care. Dr. Christensen outlines the unique safety hazards that nurses face and shares prevention strategies on both the national level and within institutions that can be carried out to protect nursing staff in the workplace.  

Oncology Data Advisor® · New and Exciting Directions in Leukemia Research: Fellows Forum With Sunil Iyer, MD Oncology Data Advisor® is excited to announce the launch of the Fellows Forum, a new resource featuring expert perspectives geared toward Hematology/Oncology Fellows. In this interview, Dr. Sunil Iyer, Chief Hematology/Oncology Fellow at the University of Miami, Florida, discusses his leukemia research, exciting new treatment directions, and what to look forward to in the next several years regarding this field.

Oncology Data Advisor® · Advocating for Equitable Care in Multiple Myeloma: With Shakira Grant, MBBS In honor of National Minority Health Month, Dr. Shakira Grant, Assistant Professor at the University of North Carolina at Chapel Hill, sat down with Oncology Data Advisor to talk about her research surrounding racial disparities faced by patients with multiple myeloma. Dr. Grant outlines the existing barriers to equitable health care and shares valuable advice on steps that oncology clinicians can take to make health care more accessible for their patients of minority populations.  

Oncology Data Advisor® · Incorporating Patient-Reported Outcomes Into Prostate Cancer Treatment With Lisa Gudenkauf, PhD At the recent American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Lisa Gudenkauf, an Applied Research Scientist at Moffitt Cancer Center, presented her team's research regarding the Functional Assessment of Cancer Therapy—Radionuclide Therapy (FACT-RNT), a novel patient-reported outcomes (PRO) measure for patients with prostate cancer. In this follow-up interview, Dr. Gudenkauf shares more about how the measure was developed, its importance for capturing the patient experience, and its future implementation into both clinical practice and trials.  

Oncology Data Advisor™ · Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With...

Oncology Data Advisor™ · Rare Disease Day With Thomas Abrams, MD; Maria Badillo, RN, OCN®, CCRP; and Ulka Vaishampayan, MD In honor of Rare Disease Day on February 28, the Oncology Data Advisor Editorial Board held a live panel discussion that featured updates on rare gastrointestinal cancers from Dr. Thomas Abrams, Assistant Professor of Medicine at Harvard Medical School; perspectives on nursing management of mantle cell lymphoma from Maria Badillo, Research Nurse Manager at MD Anderson Cancer Center; and updates on rare genitourinary cancers from Dr. Ulka Vaishampayan, Professor of Internal Medicine at the University of Michigan Rogel Cancer Center.  

Oncology Data Advisor™ · Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD Last year, Dr. Ticiana Leal, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, recorded a continuing medical education (CME)/nursing continuing professional development (NCPD)–accredited activity titled Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer (NSCLC). With numerous developments in the field occurring since recording the activity, including new FDA approvals and clinical trial results, Dr. Leal sat down with Oncology Data Advisor to provide an update on the rapidly evolving field of NSCLC immunotherapy.  

Oncology Data Advisor™ · Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Habte Yimer of Texas Oncology sat down with Oncology Data Advisor to elaborate on the promising results of brentuximab vedotin for patients with advanced-stage classical Hodgkin lymphoma, including the most recent data and future directions for the trial.  

Oncology Data Advisor™ · Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD At the recent American Society of Hematology (ASH) Annual Meeting, Dr. Ira Zackon sat down with Oncology Data Advisor to discuss his abstract regarding real-world treatment patterns and survival outcomes among patients with myelodysplastic syndromes (MDS), including ways for making clinical trial data applicable for patients treated in the community oncology setting.